This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. The FDA cleared BrainsWay D treatment of Major Depression in patients who failed to respond to one or more anti-depressants in the current episode.
Ms. Tsafrir is an expert in economics, accounting and banking. She is an independent consultant providing financial consulting to organizations and individuals, as well as a director in several enterprises, including Altusher Shacham Investments, Kadimastam and the Mediterranean Towers.
Ms. Tsafrir worked at Discount Bank for 3 years as a Business Development Manager, and at Bank Leumi for 15 years in a variety of roles, establishing and managing the branch of capital market
customers, and serving as a commercial banking manager and a macro financial expert.
Ms. Tsafrir earned a BA (cum laude) in Finance and an MA in Finance, both from Tel Aviv University.